SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 299 filers reported holding SEATTLE GENETICS INC in Q1 2017. The put-call ratio across all filers is 0.82 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $757,000 | +25.7% | 3,867 | +9.2% | 0.40% | +39.3% |
Q2 2020 | $602,000 | +1.0% | 3,541 | -31.5% | 0.28% | +16.3% |
Q1 2020 | $596,000 | -6.9% | 5,168 | -7.8% | 0.24% | +133.3% |
Q4 2019 | $640,000 | -25.9% | 5,604 | -44.6% | 0.10% | -39.7% |
Q3 2019 | $864,000 | +5.6% | 10,120 | -14.4% | 0.17% | +1.2% |
Q2 2019 | $818,000 | +44.8% | 11,817 | +18.6% | 0.17% | +77.3% |
Q4 2018 | $565,000 | -38.7% | 9,963 | -16.6% | 0.10% | +2.1% |
Q3 2018 | $922,000 | +24.6% | 11,953 | +7.2% | 0.10% | -85.5% |
Q2 2018 | $740,000 | -19.1% | 11,148 | -36.2% | 0.65% | -17.6% |
Q1 2018 | $915,000 | -7.6% | 17,480 | -5.5% | 0.79% | -36.1% |
Q4 2017 | $990,000 | +12.4% | 18,503 | +14.3% | 1.24% | +943.7% |
Q3 2017 | $881,000 | +5.1% | 16,188 | 0.0% | 0.12% | -4.8% |
Q2 2017 | $838,000 | -19.0% | 16,188 | -1.7% | 0.12% | -32.1% |
Q1 2017 | $1,035,000 | +31.8% | 16,461 | +10.6% | 0.18% | -21.4% |
Q4 2016 | $785,000 | -9.2% | 14,878 | -7.1% | 0.23% | -44.0% |
Q3 2016 | $865,000 | +53.1% | 16,008 | +14.4% | 0.42% | -0.2% |
Q2 2016 | $565,000 | +10.8% | 13,991 | -3.8% | 0.42% | -40.4% |
Q1 2016 | $510,000 | -21.9% | 14,541 | 0.0% | 0.70% | -60.8% |
Q4 2015 | $653,000 | – | 14,541 | – | 1.79% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 51,049,760 | $3,738,884,000 | 23.93% |
Lagoda Investment Management, L.P. | 76,873 | $5,630,000 | 7.16% |
Matrix Capital Management Company, LP | 3,141,852 | $230,109,000 | 6.14% |
DOMINI IMPACT INVESTMENTS LLC | 3,120 | $229,000 | 3.51% |
Opus Point Partners Management, LLC | 17,832 | $1,306,000 | 1.77% |
Capital International Sarl | 188,200 | $13,784,000 | 1.72% |
EMORY UNIVERSITY | 33,368 | $2,444,000 | 1.72% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 60,900 | $4,460,000 | 1.65% |
CAPITAL GUARDIAN TRUST CO | 1,358,254 | $99,415,000 | 1.32% |
Rhenman & Partners Asset Management AB | 150,598 | $11,030,000 | 1.29% |